[HTML][HTML] Comparison of selegiline and rasagiline therapies in Parkinson disease: a real-life study
C Peretz, H Segev, V Rozani, T Gurevich… - Clinical …, 2016 - journals.lww.com
Background We aimed to compare indicators of Parkinson disease (PD) progression
between patients first prescribed either selegiline or rasagiline as their antiparkinsonian
drugs (APDs) on the basis of real-life data. Methods Pharmacy data on members of a large
Israeli health maintenance organization, treated as patients with PD during 2001–2012 and
prescribed selegiline or rasagiline as their first APD, were analyzed. The first APD was
selegiline for 349 patients (2001–2006) and rasagiline for 485 patients (2007–2012). Time …
between patients first prescribed either selegiline or rasagiline as their antiparkinsonian
drugs (APDs) on the basis of real-life data. Methods Pharmacy data on members of a large
Israeli health maintenance organization, treated as patients with PD during 2001–2012 and
prescribed selegiline or rasagiline as their first APD, were analyzed. The first APD was
selegiline for 349 patients (2001–2006) and rasagiline for 485 patients (2007–2012). Time …
以上显示的是最相近的搜索结果。 查看全部搜索结果